Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert-Duchamp, M Hites… - medRxiv, 2022 - medrxiv.org
Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …
被引用次数：4 相关文章
[HTML] medrxiv.org

[HTML][HTML] Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert-Duchamp, M Hites… - medRxiv, 2022 - medrxiv.org
Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert-Duchamp, M Hites… - 2023 - cnrs.hal.science
Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert-Duchamp, M Hites… - 2022 - lilloa.univ-lille.fr
Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the
DisCoVeRy randomised, controlled, open-label trial Toggle navigation English français Aide …

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert-Duchamp, M Hites… - 2023 - hal.science
Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …
[HTML] europepmc.org

[HTML][HTML] Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert-Duchamp, M Hites… - 2022 - europepmc.org
Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …
[HTML] medrxiv.org

[HTML][HTML] 10 Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert Duchamp, M Hites… - connect.medrxiv.org
medrXiv Archive Skip to main content Home About Submit Alerts RSS Select an archive month
2019-06 2019-07 2019-08 2019-09 2019-10 2019-11 2019-12 2020-01 2020-02 2020-03 …

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert-Duchamp, M Hites… - 2023 - u-picardie.hal.science
Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen …

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, MB Duchamp, M Hites, NP Smadja, J Poissy… - 2022 - pesquisa.bvsalud.org
Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the
DisCoVeRy randomised, controlled, open-label trial | PREPRINT-MEDRXIV loading 1 2 3 +A …
[HTML] medrxiv.org

[HTML][HTML] 10 Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

F Ader, M Bouscambert Duchamp, M Hites… - connect.medrxiv.org
medrXiv Archive Skip to main content Home About Submit Alerts RSS Select an archive month
2019-06 2019-07 2019-08 2019-09 2019-10 2019-11 2019-12 2020-01 2020-02 2020-03 …